Segment Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2025 USD ($) segment	Mar. 31, 2024 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	1
Number of operating segments | segment	1
Segment Reporting Information [Line Items]
Total research and development expenses	$ 60,729	$ 54,645
Total selling, general, and administrative expenses	63,422	69,194
Reportable Segment
Segment Reporting Information [Line Items]
Personnel compensation and related costs	24,079	28,008
Licensing fees	19,997	0
CROs/CMOs/Investigators expenses	9,830	19,904
Other costs	6,823	6,733
Total research and development expenses	60,729	54,645
Clinical programs	28,092	18,788
Pre-Clinical programs	3,314	2,049
Unallocated research and development expenses	29,323	33,808
Total selling, general, and administrative expenses	63,422	69,194
Selling and marketing expenses	41,939	43,594
General and administrative expenses	21,483	25,600
Reportable Segment | Selling, general and administrative
Segment Reporting Information [Line Items]
Personnel compensation and related costs	40,643	45,894
Other costs	$ 22,779	$ 23,300